ZVSA

ZyVersa Therapeutics, Inc. - Common Stock (ZVSA)

About ZyVersa Therapeutics, Inc. - Common Stock (ZVSA)

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.

Details

Daily high
$0.74
Daily low
$0.69
Price at open
$0.70
52 Week High
$6.70
52 Week Low
$0.55
Market cap
1.8M
Dividend yield
0.00%
Volume
123,026
Avg. volume
6.6M
P/E ratio
-.06

ZyVersa Therapeutics, Inc. - Common Stock News

Details

Daily high
$0.74
Daily low
$0.69
Price at open
$0.70
52 Week High
$6.70
52 Week Low
$0.55
Market cap
1.8M
Dividend yield
0.00%
Volume
123,026
Avg. volume
6.6M
P/E ratio
-.06